与XRCC2结合的PARP1促进结直肠癌中的瘤进展
Kaiwu Xu1, Zhige Yu1, Tailiang Lu1
1Department of Gastrointestinal Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, People's Republic of China.
聚 (ADP-ribose) 聚合酶1 (PARP1) 在结直肠癌 (CRC) 中被上调,并促进瘤生长. PARP1表达与CRC进展和患者存活率相关,突出显示其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 多 (ADP-ribose) 聚合酶1 (PARP1) 对于DNA修复至关重要,但在未修复的DNA断裂中持续激活可能导致细胞死亡.
- PARP1在基因交换激活中的作用表明它与结直肠癌 (CRC) 的发展有关,尽管其确切的机制尚不清楚.
研究的目的:
- 研究PARP1在结直肠癌中的表达和作用.
- 确定PARP1表达和临床病理特征和CRC患者的存活率之间的相关性.
主要方法:
- 免疫组织化学评估212名CRC患者的PARP1表达.
- 构建具有不同PARP1表达水平的CRC细胞系.
- 细胞增殖试验 (CCK-8,殖民地形成) 和免疫沉 (IP) 来分析PARP1-XRCC2相互作用.
主要成果:
- 与相邻的非癌性组织相比,PARP1在CRC组织中显著上调.
- 高PARP1表达与差异化不良,高级TNM阶段,更深入的入侵,转移和生存率降低相关.
- 过度表达PARP1促进了CRC细胞增殖,并证实了它与XRCC2的相互作用;XRCC2抑制抑制了PARP1诱导的增殖.
结论:
- 在结直肠癌中,PARP1被上调,并驱动瘤细胞的增殖.
- 在CRC患者中,PARP1表达水平与关键临床病理特征和5年生存率有显著的关联.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
相关概念视频
Restarting Stalled Replication Forks
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
